Association of four common SNPs in microRNA polymorphisms with the risk of hepatocellular carcinoma

被引:3
作者
Li, Xinhong [1 ]
Li, Kai [2 ]
Wu, Zhongjun [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Chongqing 400016, Peoples R China
[2] Baotou Tumor Hosp, Dept Gen Med, Baotou 014000, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2015年 / 8卷 / 08期
关键词
MicroRNA; polymorphism; hepatocellular carcinoma; MIR-146A; CANCER; MIR-196A2;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We conducted a case-control study to investigate genetic variants of miR-146a rs2910164, miR-196a2 rs11614913, miR-149 rs2292832 and miR-499 rs3746444 in the development of HCC in a Chinese population. This case-control study included 266 HCC patients and 266 control subjects between January 2012 and December 2013. Conditional logistical regression analysis indicated that TT genotype and T allele of miR-196a2 rs11614913 carried a 2.29-fold (95% CI = 1.30-4.05) and 1.60-fold (95% CI = 1.11-2.32) increased risk of HCC when compared with CC genotype, respectively. The subgroup analysis indicated that the effect of miR-196a2 rs11614913 polymorphism was influence by HBV infection. HBV infection subjects carrying the CT + TT genotype of miR-196a2 rs11614913 had an increased risk of HCC, and the OR (95% CI) was 2.89 (1.19-7.02). In conclusion, miR-196a2 rs11614913 polymorphism may contribute to identifying individuals, especially in HBV-infected subjects, who are at high risk for HCC.
引用
收藏
页码:9560 / 9566
页数:7
相关论文
共 23 条
  • [1] A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study
    Akkiz, H.
    Bayram, S.
    Bekar, A.
    Akgollu, E.
    Ulger, Y.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2011, 18 (07) : E399 - E407
  • [2] [Anonymous], 2020, CA Cancer J Clin, DOI DOI 10.3322/CAAC.21590
  • [3] Common genetic variants in pre-microRNAs and risk of breast cancer in the North Indian population
    Bansal, C.
    Sharma, K. L.
    Misra, Sanjeev
    Srivastava, A. N.
    Mittal, Balraj
    Singh, U. S.
    [J]. ECANCERMEDICALSCIENCE, 2014, 8
  • [4] MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004)
    Bartel, David P.
    [J]. CELL, 2007, 131 (04) : 11 - 29
  • [5] MicroRNA signatures in human cancers
    Calin, George A.
    Croce, Carlo M.
    [J]. NATURE REVIEWS CANCER, 2006, 6 (11) : 857 - 866
  • [6] Polymorphisms in microRNA targets: a gold mine for molecular epidemiology
    Chen, Kexin
    Song, Fengju
    Calin, George A.
    Wei, Qingyi
    Hao, Xishan
    Zhang, Wei
    [J]. CARCINOGENESIS, 2008, 29 (07) : 1306 - 1311
  • [7] miR-146a G > C polymorphisms and risk of hepatocellular carcinoma in a Chinese population
    Cong, Ning
    Chen, Hua
    Bu, Wen-Zhe
    Li, Jin-Peng
    Liu, Ning
    Song, Jin-Long
    [J]. TUMOR BIOLOGY, 2014, 35 (06) : 5669 - 5673
  • [8] Evaluation of genetic variants in miRNAs in patients with colorectal cancer
    Dikaiakos, Panagiotis
    Gazouli, Maria
    Rizos, Spyros
    Zografos, George
    Theodoropoulos, George E.
    [J]. CANCER BIOMARKERS, 2015, 15 (02) : 157 - 162
  • [9] Genetic variations in microRNAs and the risk and survival of renal cell cancer
    Du, Mulong
    Lu, Desheng
    Wang, Qiaoyan
    Chu, Haiyan
    Tong, Na
    Pan, Xuping
    Qin, Chao
    Yin, Changjun
    Wang, Meilin
    Zhang, Zhengdong
    [J]. CARCINOGENESIS, 2014, 35 (07) : 1629 - 1635
  • [10] Oncomirs - microRNAs with a role in cancer
    Esquela-Kerscher, A
    Slack, FJ
    [J]. NATURE REVIEWS CANCER, 2006, 6 (04) : 259 - 269